Development of insulin loaded mesoporous silica injectable particles layered by chitosan as a controlled release delivery system

Int J Pharm. 2014 Jan 30;461(1-2):448-58. doi: 10.1016/j.ijpharm.2013.12.014. Epub 2013 Dec 22.

Abstract

The present work investigated the possibility of using mesoporous silica nanoparticles coated with low molecular weight chitosan as an injectable controlled release carrier of insulin. Insulin was totally encapsulated in particles. Surface tension measurements indicated that insulin was absorbed into mesoporous silica pores and interacted with chitosan. The stability of the encapsulated insulin was confirmed by different analytical methods such as RP-HPLC, FTIR and CD. Furthermore, the thermal stability using DSC was in the favor of the encapsulated insulin compared to free insulin. In vivo results indicated that insulin release was prolonged after loading into mesoporous silica nanoparticles. Such particles could be a potential carrier to control the release of insulin.

Keywords: Chitosan; Controlled release; Injectable; Insulin; Nanoparticles.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Chitosan / chemistry*
  • Chromatography, High Pressure Liquid / methods
  • Chromatography, Reverse-Phase / methods
  • Circular Dichroism
  • Delayed-Action Preparations
  • Drug Carriers / chemistry
  • Drug Delivery Systems*
  • Drug Stability
  • Hypoglycemic Agents / administration & dosage
  • Insulin / administration & dosage*
  • Molecular Weight
  • Nanoparticles
  • Porosity
  • Rabbits
  • Silicon Dioxide / chemistry*
  • Spectroscopy, Fourier Transform Infrared

Substances

  • Delayed-Action Preparations
  • Drug Carriers
  • Hypoglycemic Agents
  • Insulin
  • Silicon Dioxide
  • Chitosan